Related Experiment Video
Updated: Jul 10, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Improved cognitive function as a consequence of hepatitis C virus treatment.
H H Thein1, P Maruff, M D Krahn
1National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia.
HIV Medicine
|October 20, 2007
Summary
Achieving sustained virological response (SVR) after hepatitis C virus (HCV) treatment significantly improves cognitive function. These cognitive benefits are independent of mood and quality of life changes in patients with HCV.
Area of Science:
- Neurovirology
- Cognitive Neuroscience
- Hepatology
Background:
- Hepatitis C virus (HCV) infection can affect the central nervous system.
- The impact of successful HCV treatment on cognitive function remains an area of active research.
- Understanding these effects is crucial for comprehensive patient care.
Purpose of the Study:
- To determine if treatment-induced clearance of HCV improves cognitive function.
- To assess the relationship between sustained virological response (SVR) and cognitive performance.
- To differentiate the cognitive effects of HCV from mood and quality of life factors.
Main Methods:
- Prospective study of 19 HCV-monoinfected and 15 HIV/HCV-coinfected patients undergoing antiviral therapy.
- Neuropsychological testing, mood assessments (Depression Anxiety Stress Scales), and Short Form-36 health survey were administered.
- Cognitive function, mood, and health-related quality of life (HRQOL) were evaluated before and after treatment.
Main Results:
- Pretreatment cognitive function, mood, and HRQOL were comparable between HCV monoinfected and HIV/HCV coinfected groups.
- Sustained virological response (SVR) rates were high and similar in both patient groups (68% vs. 73%).
- Achieving SVR was linked to significant enhancements in specific cognitive measures, irrespective of HRQOL improvements.
Conclusions:
- Successful HCV treatment leading to SVR demonstrates a positive impact on cognitive function.
- These cognitive improvements appear to be a direct effect of viral clearance, separate from mood and HRQOL changes.
- Findings support the notion that HCV itself has direct cognitive consequences.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...